Literature DB >> 16720209

Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients.

Parmjeet S Randhawa1, Iulia Popescu, Camila Macedo, Adriana Zeevi, Ron Shapiro, Abhay N Vats, Diana Metes.   

Abstract

BK virus (BKV) infections after renal transplantation are increasingly recognized. Development of immune monitoring strategies against BKV requires definition of antigenic epitopes. Hence, T cells from HLA-A02-positive healthy subjects and kidney transplant recipients were stimulated by BKV lysate pulsed on mature autologous dendritic cells and screened against four different T antigen peptides or against BKV lysate. IFN-gamma production was measured by ELISPOT assays. The peptide BKV362-371 (MLTERFNHIL) was naturally processed and recognized by five of six healthy subjects (39 +/- 11 IFN-gamma spots/100,000 cells) and five of seven kidney transplant recipients (21 +/- 12 IFN-gamma spots). Less frequent and weaker CD8+ T-cell responses were detected against three other peptides. Thus, BKV large T antigen is a target for CD8+ T-cell immunity. T-antigen-specific T-cytotoxic cells circulate in healthy blood donors, implying that transient expression of T antigen presumably occurs at sites of viral latency and helps maintain a constant pool of circulating CD8+ T memory cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720209     DOI: 10.1016/j.humimm.2006.02.031

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  10 in total

1.  The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Chunqing Luo; Ron Shapiro; Diana Metes; Geetha Chalasani; Parmjeet S Randhawa
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

Review 2.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

3.  Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia.

Authors:  Kosuke Masutani; Ron Shapiro; Amit Basu; Henkie Tan; Toshiharu Ninomiya; Parmjeet Randhawa
Journal:  Transplantation       Date:  2012-07-15       Impact factor: 4.939

4.  Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation.

Authors:  A Chakera; S Bennett; S Lawrence; O Morteau; P D Mason; C A O'Callaghan; R J Cornall
Journal:  Clin Exp Immunol       Date:  2011-06-14       Impact factor: 4.330

5.  HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Diana Metes; Marta Bueno; Adriana Zeevi; Ron Shapiro; Raphael Viscidi; Parmjeet S Randhawa
Journal:  Hum Immunol       Date:  2009-05-14       Impact factor: 2.850

6.  BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.

Authors:  Yiping Chen; Jennifer Trofe; Jennifer Gordon; Patrick Autissier; E Steve Woodle; Igor J Koralnik
Journal:  J Clin Virol       Date:  2008-03-04       Impact factor: 3.168

Review 7.  BK virus nephritis after renal transplantation.

Authors:  Aaron Dall; Sundaram Hariharan
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

8.  Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors.

Authors:  Maurizio Provenzano; Laura Bracci; Stephen Wyler; Tvrtko Hudolin; Giovanni Sais; Rainer Gosert; Paul Zajac; Giorgio Palu'; Michael Heberer; Hans H Hirsch; Giulio C Spagnoli
Journal:  J Transl Med       Date:  2006-11-10       Impact factor: 5.531

Review 9.  Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.

Authors:  Patrizia Comoli; Michela Cioni; Sabrina Basso; Chiara Gagliardone; Leonardo Potenza; Enrico Verrina; Mario Luppi; Marco Zecca; Gian Marco Ghiggeri; Fabrizio Ginevri
Journal:  Clin Dev Immunol       Date:  2013-08-13

10.  Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.

Authors:  M Cioni; C Leboeuf; P Comoli; F Ginevri; H H Hirsch
Journal:  Am J Transplant       Date:  2016-02-17       Impact factor: 8.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.